Versigent logo

Versigent

VGNT | NYSE
Chart Builder DCF Calculator
$41.91
+$0.85 (+2.07%)
Nov 2, 2026, 12:16 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
Revenue
8.82B 8.31B 8.83B 8.02B
Cost of Revenue
7.73B 7.36B 7.76B 7.15B
Gross Profit
1.09B 947M 1.08B 870M
Operating Income
670M 536M 687M 519M
Interest Income
3M 4M 4M 1M
Pretax Income
540M 473M 596M 505M
Net Income
528M 408M 423M 454M
Selling & General & Admin
145M 126M 115M 104M
Research & Development
274M 285M 273M 247M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
419M 411M 388M 351M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
8.15B 7.77B 8.15B 7.5B
Income Tax Expense
-6M 39M 144M 53M
Shares Outstanding (Basic)
71.05M 71.05M 71.05M 71.05M
Shares Outstanding (Diluted)
71.05M 71.05M 71.05M 71.05M
EPS (Basic)
7.43 5.74 5.95 6.39
EPS (Diluted)
7.43 5.74 5.95 6.39
EBITDA
897M 738M 892M 710M
EBIT
670M 536M 687M 519M
Depreciation & Amortization
227M 202M 205M 191M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.